Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study.

PloS one - 28 Jan 2011

Van den Eede Peter, Soto-Calle Veronica E, Delgado Christopher, Gamboa Dionicia, Grande Tanilu, Rodriguez Hugo, Llanos-Cuentas Alejandro, Anné Jozef, D'Alessandro Umberto, Erhart Annette

Abstract excerpt

BACKGROUND: There is an increasing body of literature reporting treatment failure of the currently recommended radical treatment of Plasmodium vivax infections. As P. vivax is the main malaria species outside the African continent, emerging tolerance to its radical treatment regime could have maj...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Protozoan
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Longitudinal Studies

Share to Malaria, Vivax

Share to Plasmodium vivax

Share to Polymerase Chain Reaction

Share to Recurrence

Source

Open in PubMed Open full text

Identifiers

PMID: 21297986
DOI: 10.1371/journal.pone.0016257
PMCID: PMC3030575

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21297986-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study.PMID 21297986Read ↗

Population structure and spatio-temporal transmission dynamics of Plasmodium vivax after radical cure treatment in a rural village of the Peruvian Amazon.Semantic proximity Read ↗

Genetic variation and recurrent parasitaemia in Peruvian Plasmodium vivax populations.Semantic proximity Read ↗

Exploration of Plasmodium vivax transmission dynamics and recurrent infections in the Peruvian Amazon using whole genome sequencing.Semantic proximity Read ↗

Molecular and epidemiological characterization of Plasmodium vivax recurrent infections in southern Mexico.Semantic proximity Read ↗

Individual Plasmodium vivax msp1 variants within polyclonal P. vivax infections display different propensities for relapse.Semantic proximity Read ↗

A case of Plasmodium malariae recurrence: recrudescence or reinfection?Semantic proximity Read ↗

Microgeographical differences of Plasmodium vivax relapse and re-infection in the Peruvian Amazon.Semantic proximity Read ↗

High Prevalence, Genetic Diversity and Temporal Differentiation of Plasmodium vivax in a Remote Hard-to-Reach Community from the Peruvian Amazon Region.Semantic proximity Read ↗

Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in NepalSemantic proximity Read ↗

Multilocus genotyping reveals high heterogeneity and strong local population structure of the Plasmodium vivax population in the Peruvian Amazon.Semantic proximity Read ↗

Revisiting <i>Plasmodium vivax</i> molecular correctionSemantic proximity Read ↗

Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.